ResearcherNagoya UniversityActive in the last 2 years

Xingxing Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8173-7148; OpenAlex author ID A5100673280. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2026: 1 paper

Papers 1

Transgelin defines pro-tumorigenic cancer-associated fibroblasts in pancreatic cancer. Co-author DOI 10.1038/s41416-025-03299-5 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Reo Maruyama · 1 shared paper, 2026 · strength 0.25
- Paper Transgelin defines pro-tumorigenic cancer-associated fibroblasts in pancreatic cancer. DOI 10.1038/s41416-025-03299-5 ↗
Shinji Mii · 1 shared paper, 2026 · strength 0.25
- Paper Transgelin defines pro-tumorigenic cancer-associated fibroblasts in pancreatic cancer. DOI 10.1038/s41416-025-03299-5 ↗
Keiko Shinjo · 1 shared paper, 2026 · strength 0.25
- Paper Transgelin defines pro-tumorigenic cancer-associated fibroblasts in pancreatic cancer. DOI 10.1038/s41416-025-03299-5 ↗
Atsushi Enomoto · 1 shared paper, 2026 · strength 0.25
- Paper Transgelin defines pro-tumorigenic cancer-associated fibroblasts in pancreatic cancer. DOI 10.1038/s41416-025-03299-5 ↗
Yutaka Kondo · 1 shared paper, 2026 · strength 0.25
- Paper Transgelin defines pro-tumorigenic cancer-associated fibroblasts in pancreatic cancer. DOI 10.1038/s41416-025-03299-5 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.